Yongzhe Piao
Yongzhe Piao publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies and Esophageal Cancer Research and Treatment.
- World rank
- #1,901,330 of 7,710,434 ranked researchers
- Rank in Japan
- #33,691 of 383,136
- Works
- 66
- Citations
- 1.1k
- Citations per work
- 16.3
What does Yongzhe Piao research?
Yongzhe Piao's work is mostly in Medicine (51%), Biochemistry, Genetics and Molecular Biology (13%), Agricultural and Biological Sciences (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3451.1%
- Medicine3451.1%
- Everything else2132.3%
- Life Sciences1116.6%
- 1Pulmonary and Respiratory Medicine19% of their works
- 2Oncology18% of their works
- 3Molecular Biology13% of their works
- 4Surgery10% of their works
- 5Food Science4% of their works
- 6Gastroenterology4% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Colorectal Cancer Treatments and Studies
- Esophageal Cancer Research and Treatment
- Advanced biosensing and bioanalysis techniques
- Gastrointestinal Tumor Research and Treatment
- HER2/EGFR in Cancer Research
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Fermentation and Sensory Analysis
Which keywords describe Yongzhe Piao's research?
The keywords of their largest research topics: Chemotherapy, Endoscopic Resection, Gastric Cancer, Molecular Characterization, Epidemiology, Prognostic Factors, Surgical Management and Cetuximab.
- Microbial Modulation
- Self-Assembly
- HER2
- Cholangiocarcinoma
- Biliary Tract Cancer
- Esophageal Carcinoma
- Cetuximab
- Prognostic Factors
- Molecular Characterization
- Endoscopic Resection
- Chemotherapy
- Gastric Cancer
- Epidemiology
- Surgical Management
- KRAS Mutations
- Preoperative Chemoradiotherapy
- Breast Cancer
- DNA nanotechnology
- Imatinib Mesylate
- Sunitinib
- Wine Yeasts
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Chemotherapy343 topics
- Endoscopic Resection262 topics
- Gastric Cancer201 topic
- Molecular Characterization201 topic
- Epidemiology112 topics
- Prognostic Factors102 topics
- Surgical Management102 topics
- Cetuximab91 topic
- KRAS Mutations91 topic
- Esophageal Carcinoma61 topic
- Preoperative Chemoradiotherapy61 topic
- Biliary Tract Cancer51 topic
- Breast Cancer51 topic
- Cholangiocarcinoma51 topic
- DNA nanotechnology51 topic
- HER251 topic
- Imatinib Mesylate51 topic
- Self-Assembly51 topic
- Sunitinib51 topic
- Microbial Modulation41 topic
- Wine Yeasts41 topic
Where does Yongzhe Piao work?
Yongzhe Piao's main affiliation in the publication record is Eli Lilly (Japan), Japan.
How many publications and citations does Yongzhe Piao have?
OpenAlex counts 66 works and 1,073 citations for Yongzhe Piao, an h-index of 16, ranking #1,901,330 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Yongzhe Piao. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.